The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma
Launched by WUHAN UNION HOSPITAL, CHINA · Dec 2, 2022
Trial Information
Current as of January 22, 2025
Unknown status
Keywords
ClinConnect Summary
Melanoma is an aggressive malignancy with a high mortality rate. Accurate diagnosis and prognostic risk assessment are essential to the clinical management of melanoma. Melanin is present in most melanoma and has become a potential target for melanoma. This team has successfully synthesized a positron nuclide targeting melanin probe named 18F-PFPN (18F-N-(2-diethylaminoethyl)-4-(2-\[2-ethoxy\]-ethoxy) pyridine), which has been proven to be safe and well-tolerated. It has shown excellent diagnostic value in both primary and metastatic melanoma. This prospective study was designed to further ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with histopathologically confirmed melanoma;
- • Patients with complete clinical and follow-up data (including TNM stage, subtypes, and treatment strategies).
- Exclusion Criteria:
- • Uncertain histopathology;
- • A history of other malignancies.
Trial Officials
Xiaoli Lan, PhD
Study Director
Wuhan Union Hospital, China
About Wuhan Union Hospital, China
Wuhan Union Hospital, affiliated with Huazhong University of Science and Technology, is a leading medical institution located in Wuhan, China. Renowned for its comprehensive healthcare services and advanced research capabilities, the hospital plays a pivotal role in clinical trials aimed at enhancing medical knowledge and patient care. With a commitment to innovation and excellence, Wuhan Union Hospital collaborates with various stakeholders to conduct rigorous and ethically sound clinical research, contributing significantly to the advancement of medical science and public health both domestically and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials